Tuesday, 02 January 2024 12:17 GMT

Claigan Webinar - Canadian PFAS Reporting New - Section 71 Reporting Of PFAS In Canada


(MENAFN- PR Newswire) OTTAWA, ON, Aug. 8, 2024 /PRNewswire/ - On August 14, Claigan Environmental Inc. ( ) will be presenting a webinar on the newly released PFAS reporting requirements in Canada.

On July 27, the Canadian government published a Section 71 notice requiring companies to report the PFAS in their products by January 29, 2025.
The PFAS reporting includes most PFAS polymers, elastomers, fluids, and salts in chemical mixtures and in physical products.
Unlike the US TSCA PFAS reporting requirements, medical devices and pharmaceuticals (and other FDA / Health Canada regulated products) are in scope of the Canadian requirements.

Claigan's webinar will begin with an overview of the scope of reporting including thresholds and product types.
The second half of the webinar will dive more into the reporting details with comparisons to other jurisdictions (such as US TSCA reporting).

Key topics will include:

  • A simplified overview of Section 71 notices and CEPA
  • Reporting requirements
  • Companies and products in scope
  • Thresholds for reporting
  • PFAS in scope
  • Comparison to US TSCA PFAS reporting
  • Practical approaches

Note - due to the expected demand, there will be two (2) webinars scheduled on August 14.

Webinars - Canadian
PFAS Reporting

Date:
14 August 2024

Time: 10am and 2pm

Duration:
1 hour including Q&A

To
Register:

10am -
2pm -

or on Claigan's Website at /webinars

About Claigan Environmental ( )

Claigan is the leading provider in restricted materials compliance.
Claigan has tested thousands of products for PFAS, REACH, POP, TSCA, Prop 65, and related global compliance. Claigan is an ISO 17025 certified laboratory and is dedicated to providing practical solutions for supply chain due diligence and social responsibility.

At Claigan, our philosophy is simple: More Results, Less Journey.

SOURCE Claigan Environmental Inc.

MENAFN08082024003732001241ID1108532729



PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search